Cargando…

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010

BACKGROUND: Invasive meningococcal disease (IMD) caused by serogroup B is the last major serogroup in Canada to become vaccine-preventable. The anticipated availability of vaccines targeting this serogroup prompted an assessment of the epidemiology of serogroup B disease in Ontario, Canada. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dang, Vica, Jamieson, Frances B, Wilson, Sarah, Rawte, Prasad, Crowcroft, Natasha S, Johnson, Karen, Tsang, Raymond S W, Deeks, Shelley L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472197/ https://www.ncbi.nlm.nih.gov/pubmed/22928839 http://dx.doi.org/10.1186/1471-2334-12-202

Ejemplares similares

The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013
por: Desai, Shalini, et al.
Publicado: (2015)

The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009–2014
por: Bolotin, Shelly, et al.
Publicado: (2017)

Rubella immunity among prenatal women in Ontario, 2006–2010
por: Lim, Gillian H, et al.
Publicado: (2013)

New Endemic Legionella pneumophila Serogroup I Clones, Ontario, Canada
por: Tijet, Nathalie, et al.
Publicado: (2010)

The epidemiology of travel-related Salmonella Enteritidis in Ontario, Canada, 2010–2011
por: Tighe, Mary-Kathryn, et al.
Publicado: (2012)

Respiratory Virus Infection and Risk of Invasive Meningococcal Disease in Central Ontario, Canada
por: Tuite, Ashleigh R., et al.
Publicado: (2010)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
por: Lingappa, Jairam R., et al.
Publicado: (2003)

Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
por: Soeters, Heidi, et al.
Publicado: (2017)

Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007–2011
por: Wilson, Sarah E., et al.
Publicado: (2015)

Paediatric meningococcaemia in northwestern Ontario, Canada: a case for publicly funded meningococcal B vaccination
por: Eton, Vic, et al.
Publicado: (2016)

Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010
por: Marras, Theodore K., et al.
Publicado: (2013)

Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada
por: Wilson, Sarah E., et al.
Publicado: (2018)

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine
por: Tsang, Raymond S. W., et al.
Publicado: (2020)

Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study
por: Wormsbecker, Anne E., et al.
Publicado: (2015)

Encephalitis, Ontario, Canada, 2002–2013
por: Parpia, Alyssa S., et al.
Publicado: (2016)

Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015
por: Thomas, Shari, et al.
Publicado: (2017)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Improving estimates of pertussis burden in Ontario, Canada 2010–2017 by combining validation and capture-recapture methodologies
por: McBurney, Shilo H., et al.
Publicado: (2023)

Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000
por: Aguilera, Jean-François, et al.
Publicado: (2002)

Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015
por: Ramsay, Lauren C, et al.
Publicado: (2019)

Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008)

Epidemiology of invasive meningococcal disease in Canada, 2012–2019
por: Saboui, Myriam, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
por: Sáfadi, Marco Aurelio Palazzi, et al.
Publicado: (2014)

Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009–May 2010
por: Achonu, Camille, et al.
Publicado: (2011)

Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity
por: Bolotin, Shelly, et al.
Publicado: (2015)

The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
por: Wijayasri, Shinthuja, et al.
Publicado: (2019)

Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006
por: Ng, Victoria, et al.
Publicado: (2009)

Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study
por: Bolotin, Shelly, et al.
Publicado: (2019)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Meningococcal serogroups and surveillance: a systematic review and survey
por: Peterson, Meagan E, et al.
Publicado: (2019)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
por: Brode, Sarah K., et al.
Publicado: (2017)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Population-Level Impact of Ontario’s Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects
por: Wilson, Sarah E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_to0i7sgdb1vdu3daa7hfvum032